MLEC

Moolec Science S.A. MLEC

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MLEC VRAX ELAB NKGN GLMD WINT GTBP TIVC DRMA XRTX
6M -95.18 % -50.91 % -68.65 % -80.00 % -54.48 % -92.98 % -75.18 % -54.21 % 216.66 % -31.26 %
YTD -96.03 % -82.36 % -96.28 % -92.76 % -74.36 % -99.76 % -74.26 % -70.15 % 53.96 % -48.72 %
1Y -95.94 % -79.70 % -96.47 % -92.22 % -71.91 % -99.75 % -73.06 % -54.33 % 73.98 % -46.43 %
3Y -96.55 % -93.22 % -99.99 % -99.12 % -99.20 % -100.00 % -97.75 % -99.84 % -94.99 % -90.87 %
5Y -96.68 % -99.79 % -99.99 % -99.12 % -99.87 % -100.00 % -99.70 % -99.98 % -99.83 % -97.88 %
10Y -96.68 % -99.79 % -99.99 % -99.12 % -99.94 % -100.00 % -100.00 % -99.98 % -99.83 % -97.88 %
From the beginning -96.68 % -99.79 % -99.99 % -99.12 % -99.97 % -100.00 % -100.00 % -99.98 % -99.83 % -97.88 %

Dividend

XORTX Therapeutics Inc.